CRVS
Corvus Pharmaceuticals, Inc.
$9.52-0.33 (-3.35%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
Showing 10 of 26 transactions (past 365 days)
| 2026-06-15 | 2026-06-11 | Moore David Scott | Director | Award | 15,000 | $11.60 | $174,000 |
| 2026-06-15 | 2026-06-11 | Moore David Scott | Director | Purchase | 21,700 | $11.53 | $250,244 |
| 2026-06-15 | 2026-06-11 | Clark Ian T | Director | Award | 15,000 | $11.60 | $174,000 |
| 2026-06-15 | 2026-06-11 | Grais Linda | Director | Award | 15,000 | $11.60 | $174,000 |
| 2026-06-15 | 2026-06-11 | Thompson Peter A. | Director | Award | 15,000 | $11.60 | $174,000 |
| 2026-06-15 | 2026-06-11 | Van Den Broek Richard | Director | Award | 15,000 | $11.60 | $174,000 |
| 2026-05-20 | 2026-05-18 | Miller Richard A Md | CEO | Purchase | 5,000 | $12.05 | $60,250 |
| 2026-05-20 | 2026-05-18 | Miller Richard A Md | CEO | Purchase | 1,932 | $12.01 | $23,203 |
| 2026-04-27 | 2026-04-23 | Chan Andrew C. | Director | Award | 30,000 | $16.02 | $480,600 |
| 2026-01-30 | 2026-01-28 | Thompson Peter A. | Director | Exercise Conversion | 30,000 | $0.00 | $0 |
CRVS
Director
Exercise Conversion
$0
Thompson Peter A.30,000 shares @ $0.00
Filed 2026-01-30Trade 2026-01-28
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.